French Health Technology Assessment of Antineoplastic Drugs Indicated in the Treatment of Solid Tumours: Perspective for Future Trends
Crossref DOI link: https://doi.org/10.1007/s11523-015-0411-8
Published Online: 2016-02-01
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chouaid, Christos
Borget, Isabelle
Braun, Eric
Bazil, Marie-Laure
Schaetz, Dominique
Rémuzat, Cécile
Toumi, Mondher
Funding for this research was provided by:
Janssen France
License valid from 2016-02-01